With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Trib2 in the Pathogenesis of T-ALL||University of Pennsylvania / Warren Pear, M.D., Ph.D.,||Innovation Grants||2014||Pennsylvania|
|Trk-Targeted Therapy of Human Neuroblastomas||Children's Hospital of Philadelphia / Garrett Brodeur, M.D.||Bridge Grants||2014||Pennsylvania|
|Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia||Children's Hospital of Philadelphia / Jennifer Wilkes, MD||Young Investigator Grants||2014||Pennsylvania|
|Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells||Children's Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D.||Innovation Grants||2014||Pennsylvania|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|
|STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML||Baylor College of Medicine / Michele Redell, M.D./Ph.D.||Springboard Grants||2014||Texas|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|
|Cell Line and Xenograft Repository||Texas Tech University Health Sciences Center / Patrick Reynolds, MD/PhD||Catalyst Grants||2014||Texas|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|